1. Home
  2. AKBA vs NECB Comparison

AKBA vs NECB Comparison

Compare AKBA & NECB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$1.40

Market Cap

375.0M

Sector

Health Care

ML Signal

HOLD

Logo NorthEast Community Bancorp Inc.

NECB

NorthEast Community Bancorp Inc.

HOLD

Current Price

$24.63

Market Cap

344.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKBA
NECB
Founded
2007
1934
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
375.0M
344.8M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
AKBA
NECB
Price
$1.40
$24.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$5.25
$30.00
AVG Volume (30 Days)
2.2M
32.4K
Earning Date
05-07-2026
04-24-2026
Dividend Yield
N/A
4.07%
EPS Growth
93.94
N/A
EPS
N/A
3.25
Revenue
N/A
N/A
Revenue This Year
N/A
$4.85
Revenue Next Year
N/A
$8.45
P/E Ratio
N/A
$7.53
Revenue Growth
N/A
N/A
52 Week Low
$1.14
$19.27
52 Week High
$4.08
$25.65

Technical Indicators

Market Signals
Indicator
AKBA
NECB
Relative Strength Index (RSI) 49.33 50.38
Support Level $1.30 $22.47
Resistance Level $1.56 $25.42
Average True Range (ATR) 0.08 0.62
MACD -0.00 -0.05
Stochastic Oscillator 33.90 39.82

Price Performance

Historical Comparison
AKBA
NECB

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

About NECB NorthEast Community Bancorp Inc.

NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States, including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.

Share on Social Networks: